Zhixia Zhao
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 17, 2024
Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal.
Journal: Frontiers in pharmacology
Published: September 02, 2023
Pharmacokinetics and pharmacodynamics of perfluoropropane after intra-venous bolus injection of perflutren lipid microsphere injection (DEFINITY®) in healthy Chinese volunteers.
Journal: BMC pharmacology & toxicology
Published: August 23, 2023
Urinary incontinence as a possible signal of neuromuscular toxicity during immune checkpoint inhibitor treatment: Case report and retrospective pharmacovigilance study.
Journal: Frontiers in oncology
Published: May 27, 2022
Simultaneous Quantitation of Clevidipine and Its Active Metabolite H152/81 in Human Whole Blood by LC-MS/MS: Application to Bioequivalence Study.
Journal: Frontiers in chemistry
Published: January 25, 2022
Cholecystitis and cholangitis associated with lenvatinib: A pharmacovigilance study.
Journal: British journal of clinical pharmacology
Published: October 07, 2021
Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 06, 2021
Anti-angiogenic agent-associated adrenal insufficiency in immune checkpoint inhibitors-treated patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 27, 2021
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review.
Journal: Breast (Edinburgh, Scotland)
Published: April 12, 2021
Lenvatinib and osteonecrosis of the jaw: A pharmacovigilance study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 13, 2021
Study on the Relationship between Rivaroxaban and Factor Xa Activity in Blood Based on HPLC-MS/MS.
Journal: Current drug metabolism
Published: March 11, 2021
Risk of pneumonitis in cancer patients treated with PARP inhibitors: A meta-analysis of randomized controlled trials and a pharmacovigilance study of the FAERS database.
Journal: Gynecologic oncology
Published: March 10, 2021
Last Updated: 09/26/2026